Scientists at the University of Cambridge in the United Kingdom and DIOSynVax reports the first human clinical trial of a AI-designed vaccine for coronaviruses including SARS, MERS, and COVID-19 and potentially Ebola. (Medical Xpress), (AA) link embed save